Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Drug Discovery Today|May 26, 2023
Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discoverySathapana Kongsamut, Haifeng EishingdreloCurrent Chemical Genomics and Translational Medicine|January 8, 2014
Minireview: Targeting GPCR Activated ERK Pathways for Drug DiscoveryHaifeng Eishingdrelo, Sathapana KongsamutSignal Transduction and Targeted Therapy|December 22, 2017
G-protein-coupled receptors mediate 14-3-3 signal transductionHua Li, Alex Eishingdrelo, Sathapana Kongsamut, et al.Current Research in Pharmacology and Drug Discovery|August 22, 2022
Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoformsHaifeng Eishingdrelo, Xiaofa Qin, Luwa Yuan, et al.Scientific Reports|August 3, 2019
14-3-3 signal adaptor and scaffold proteins mediate GPCR traffickingLuwa Yuan, Shahar Barbash, Sathapana Kongsamut, et al.Current Chemical Genomics|December 31, 2011
A cell-based protein-protein interaction method using a permuted luciferase reporterHaifeng Eishingdrelo, Jidong Cai, Paul Weissensee, et al.Journal of Biomolecular Screening|November 2, 2014
ERK and β-arrestin interaction: a converging point of signaling pathways for multiple types of cell surface receptorsHaifeng Eishingdrelo, Wei Sun, Hua Li, et al.Brain, Behavior, and Immunity|August 15, 2024
LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease modelsSusan Acton, Michelle M O'Donnell, Kalaichitra Periyasamy, et al.Pageof 1